Viactiv® Product Line Contributes to Highest Quarterly Revenue in Company History of Approximately $3.275 Million, Shows Significant Revenue Growth from...
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy...
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with...
Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon Viactiv Omega Boost Gel Bites Provide 10x More...
Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022...
HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported...
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...
Consumers May Now Purchase Viactiv® Omega Boost Directly from Viactiv.com Viactiv® Omega Boost Gel Bites Provide 10x More Omega-3s Than the Leading...
June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial...
HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically...